Antitrust Antitrust

Alchem, Boehringer Ingelheim, others targeted in CADE probe into international scopolamine-n-butylbromide cartel

By Ana Paula Candil
  • 19 Nov 2021 11:05
  • 19 Nov 2021 11:41
Alchem International Pvt, Boehringer Ingelheim Pharma GmbH & Co. KG, five other pharmaceutical companies and 11 individuals have been targeted in an international cartel probe into scopolamine-n-butylbromide (SnBB) with effects in Brazil.

SnBB is an antispasmodic drug which can relieve painful stomach cramps.

The Administrative Council for Economic Defense, or CADE, began the formal

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News